[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@lcccc333
"I believe these could be potential takeover targets. No position in any of them. Theyre either too expensive or not at a price that would offer the kind of return Im looking for. $MDGL $BBIO $AKRO $JANX $IDYA $RVMD" @lcccc333 on X 2025-07-13 16:37:48 UTC XX followers, 1914 engagements
"@Heatlamp11 $CTMX Funding shouldnt be a problem in the near term since they raised $100M not long ago. The data coming in Q1 2026 will be really important for the stock" @lcccc333 on X 2025-07-23 15:09:01 UTC XX followers, XXX engagements
"$CRDF Was leaning bullish before the CMO change. Datas looked solid so far which to me offsets the PK concerns. If PK were a major issue hedge funds and Pfizer probably saw it too. Honestly its the sudden CMO switch thats keeping me on the sidelines. Just a gut feeling" @lcccc333 on X 2025-07-27 21:01:32 UTC XX followers, XXX engagements
"$CTMX Hope this will be another ImmunoGen" @lcccc333 on X 2025-07-06 13:59:35 UTC XX followers, XXX engagements
"$CTMX Really want to go all in. There aren't many opportunities like this - large market no competitors good efficacy and safe low MC low price proven MOA. May be I'll wait until it drops below $X if it does. It's not the time. No rush adding to my 200k shares yet" @lcccc333 on X 2025-07-03 13:08:48 UTC XX followers, 4257 engagements
"@Andre_AGTC @jfais20 I would like to know as well if possible. If I am remembering correctly the CoM patent for OJEMDA will expire soon" @lcccc333 on X 2025-07-26 17:43:06 UTC XX followers, XXX engagements
"$ABVX The last time something like this happened that comes to mind was with $MDGL. I think even those buying $ABVX today can still make money. For me however the potential reward is relatively small given the high share price and the limited number of shares I can afford" @lcccc333 on X 2025-07-23 21:00:17 UTC XX followers, XXX engagements